17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth

• প্রধান লেখক: Manali Patki (লেখক), Kiersten Giusto (লেখক), Samir Gorasiya (লেখক), Sandra E. Reznik (লেখক), Ketan Patel (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2019-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Preterm birth (PTB) is a major cause of infant mortality in the United States and around the globe. Makena^®—once-a-week intramuscular injection of 17-α Hydroxyprogesterone caproate (17P)—is the only FDA approved treatment for the prevention of PTB. Invasive delivery of 17P req...